Clinical Trial Update: Study on Paclitaxel Plus Topotecan in Comparison With Topotecan Plus Cisplatin in Recurrent or Persistent Cervical Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares paclitaxel plus topotecan to topotecan plus cisplatin in women with recurrent or persistent cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)
• Topotecan (topotecan)

Snippet

Sponsor: Institut fuer Frauengesundheit | Conditions: Recurrent, Persistent or Metastasized Cervical Cancer | Phase 3 | Status: UNKNOWN